Myrriah Chavez Tomar, PhD
Myrriah Chavez Tomar is a postdoctoral researcher in the lab of Dr. Zobeida Cruz-Monserrate at the Ohio State University Wexner Medical Center in the Department of Gastroenterology, Hepatology, and Nutrition (GHN Division). Myrriah received her B.S. in Biochemistry from the University of New Mexico in Albuquerque as an IMSD undergraduate scholar in Dr. Mary Ann Osley’s lab working on fundamental mechanisms in DNA repair using Saccharomyces cerevisiae. As an IMSD scholar, Myrriah became fascinated by laboratory research and went on to attend graduate school at The University of Colorado Anschutz Medical School in Denver, CO where she completed her Ph.D. in Molecular Biology, studying mechanisms in chromatin remodeling and replicative aging in Dr. Jessica Tyler’s lab. Myrriah’s graduate research training also included several years at MD Anderson Cancer Center in Houston, TX. Upon receiving her Ph.D., Myrriah relocated to Columbus, OH and accepted a position as an R&D scientist developing a novel protein based consumer product for the company SafeWhite Inc. Myrriah’s passion for understanding biological mechanisms led her back to academic research at the OSU Wexner Medical Center, where she currently works in translational research using pre-clinical mouse pancreatic cancer models to identify potential cancer biomarkers. The goal of her postdoctoral research is to identify mechanisms and potential patient interventions for high risk individuals with a predisposition for pancreatic cancer. In addition to research, Myrriah enjoys spending time outdoors, biking, and practicing her Hindi.